Renal Flashcards
What score is used to measure impact of LUTS on QOL? Scores?
International prostate symptoms score
20-35: severely symptomatic
8-19: moderately symptomatic
0-7: mildly symptomatic
What can cause a raised PSA?
- Prostate cancer
- BPH
- Recent ejaculation or prostate stimulation (ideally not in past 48 hrs)
- Prostatitis
- UTI
- Vigorous exercise (notably cycling, ideally not in past 48 hrs)
Examples of alpha-blockers
- Tamsulosin
- Doxasocin
Example of 5-alpha reductase inhibitor
- Finasteride
SEs of alpha-blockers
- POSTURAL HYPOTENSION
- Dizziness
- Drowsiness
- Depression
- Dyspnoea and cough
SEs of 5-alpha reductase inhibitors
- Impotence
- Low libido
- Gynaecomastia
- Decreased prostate size
- Causes low levels of PSA
When should you refer to urology for prostate issues?
Men aged 50-69 years should be referred if the PSA is >= 3.0 ng/ml OR there is an abnormal DRE
Tx of prostate cancer
Localised (T1/T2):
- Surveillance/watchful waiting in early, multiple co-morbs, low Gleason score
- Radical prostatectomy
- External beam radiotherapy
- Brachytherapy (modification allowing internal radiotherapy)
Localized advanced (T3/T4):
- Hormone therapy (androgen-deprivation)
- Radical prostatectomy
- Radiotherapy
Hormone therapy includes:
- GnRH agonists, e.g. Goserelin
- Bicalutamide (blocks androgen receptor)
1st line investigation for prostate cancer
Multiparametric MRI
What scoring system is used to assess MRI in prostate cancer?
Likert Scale
> 3 = do biopsy
1-2 = weigh up pros/cons of doing biopsy
What scoring system is used to assess the biopsy in prostate cancer?
Gleason Score
- First number = grade most prevalent in sample
- Second number = 2nd most prevalent grade in sample
- Grades = 1-5 (5= worse)
- Add two number together (2= best, 10 = worst)
- > 8 = severe
- 6-8 = mod
- <6 = low risk
Complications of radical prostatectomy
- ERECTILE DYSFUNCTION
- incontinence
Complications of radiotherapy/brachytherapy for prostate cancer
- Proctitis (rectum inflammation) - pred suppositories can help
- Cystitis
- Increased risk of bladder/colon/rectal cancer
- Erectile dysfunction
- Incontinence
Complications of hormone therapy for prostate cancer
- Hot flushes
- Sexual dysfunction
- Gynaecomastia
- Fatigue
- Osteoporosis
Types of bladder cancer
- Transitional cell carcinoma (90%)
- Squamous cell carcinoma (5% - higher in areas of schistosomiasis)
- Adenocarcinoma, sarcoma, small-cell carincoma (rare)
Bladder cancer
Risk factors
- Smoking (x3 risk)
- Aromatic amines (dye factory - aniline dyes)
- Rubber manufacturing
- Paraplegia (x20 risk due to long term catheterisation)
- Cyclophosphamides
- Schistosomiasis - SQUAMOUS CELL
Two-week referral for bladder cancer
- Aged over 45 with unexplained visible haematuria, either without a UTI or persisting after treatment for a UTI
- Aged over 60 with microscopic haematuria (not visible but positive on a urine dipstick) PLUS:
- Dysuria or;
- Raised white blood cells on a full blood count
Consider a non-urgent referral in people over 60 with recurrent unexplained UTIs.
Presentation of renal cell carcinoma
- Haematuria
- Flank pain
- Palpable mass
Patho of renal cell carcinoma
- Adenocarcinoma
- In proximal convoluted tubules
- Solid lesions
- Up to 20% may be multifocal, 20% may be calcified and 20% may have either a cystic component or be wholly cystic
Types of renal cell carcinoma
- CLEAR CELL (80%)
- Papillary
- Chromophobe
Renal cell carcinoma risk factors
- Smoking
- Obesity
- Hypertension
- End-stage renal failure
- VON HIPPEL-LINDAU DISEASE
- Tuberous sclerosis
- Only slightly increased in patients with ADPKD
Two-week wait for renal cancer
Aged over 45 with unexplained visible haematuria, either without a UTI or persisting after treatment for a UTI
Paraneoplastic features of RCC
- Polycythaemia (secretion of unregulated erythropoeitin)
- Hypercalcaemia (secretion of hormone that mimics action of PTH)
- Hypertension (increased renin secretion, polycythaemia and physical compression)
- Stauffer syndrome - abnormal liver function tests (ALT/AST/ALP/bilirubin raised) without liver mets
RCC mets in lungs
CANNONBALL METS (clearly-defined circular opacities )
Staging of renal cell carcinoma
Stage 1: < 7cm, confined to kidney
Stage 2: > 7cm but confined to kidney
Stage 3: Local spread to nearby tissues or veins, but not beyond Gerota’s fascia
Stage 4: Spread beyond Gerota’s fascia, including mets
Mx of renal cell carcinoma
- Partial or radical nephrectomy (may include surrounding tissue, lymph nodes and even adrenalectomy)
- Arterial embolisation (cut off blood supply to kidney)
- Percutaneous cryotherapy (freeze and kill tumour cells)
- Radiofrequency ablation
- Chemo or radiotherapy (BUT RCC usually resistant)
- IL-2 and alpha-interferon
- Tyrosine kinase inhibitors (sorafenib, sunitinib)
Ix for RCC
- CT
- Biopsy should not be performed when a nephrectomy is planned but is mandatory before any ablative therapies are undertaken
- Assessment of the functioning of the contralateral kidney
Define AKI (criteria)
- Rise in creatinine > 26 micromol/L in 48 hours
- Rise in creatinine of >50% (1.5x) in 7 days
- Urine output of < 0.5ml/kg/hr for > 6 hours
AKI Stage 1
- 1.5x - 1.9x baseline creatinine
- < 0.5 ml/kg/hr UO for 6-12 hours
AKI Stage 2
- 2.0x - 2.9x baseline creatinine
- < 0.5ml/kg/hr UO for 12hrs